Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

14.52USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$14.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$15.40
52-wk Low
$12.55

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.38 December 12 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 -- -- --
(2) OUTPERFORM 2 -- -- --
(3) HOLD 0 -- -- --
(4) UNDERPERFORM 0 -- -- --
(5) SELL 0 -- -- --
No Opinion 0 -- -- --
Mean Rating 1.67 -- -- --

Consensus Estimates Analysis

Sales and Profit Figures in 
Earnings and Dividend Figures in 
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 --
Year Ending Dec-17 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-17 2 -0.38 -0.27 -0.49 --
Quarter Ending Mar-18 2 -0.30 -0.29 -0.31 --
Year Ending Dec-17 2 -1.29 -0.92 -1.66 --
Year Ending Dec-18 2 -1.36 -1.33 -1.39 --

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in 
Earnings and Dividend Figures in 
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.00 -- -- -- --
Year Ending Dec-17 0.00 -- -- -- --
Year Ending Dec-18 0.00 -- -- -- --
Earnings (per share)
Quarter Ending Dec-17 -0.38 -- -- -- --
Quarter Ending Mar-18 -0.30 -- -- -- --
Year Ending Dec-17 -1.29 -- -- -- --
Year Ending Dec-18 -1.36 -- -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 -- -- -- --
Year Ending Dec-17 -- -- -- --
Year Ending Dec-18 -- -- -- --
Earnings
Quarter Ending Dec-17 -- -- -- --
Quarter Ending Mar-18 -- -- -- --
Year Ending Dec-17 -- -- -- --
Year Ending Dec-18 -- -- -- --